MMR II is a combination vaccine used to prevent Measles, Mumps, and Rubella (German measles). It contains live attenuated viruses that stimulate the immune system to produce antibodies

Benefits of MMR II
This vaccine helps prevent Measles, Mumps, and Rubella (German measles), which are transmitted through close contact with infected individuals, primarily via saliva droplets released when coughing or sneezing.

Measles can cause widespread red rashes over the body, coughing, runny nose, eye irritation, and fever.

Mumps may result in fever, muscle pain, and swelling of the parotid (salivary) glands in the neck.

Rubella causes red rashes throughout the body, accompanied by fever and joint inflammation.
Measles infection can lead to seizures, brain damage, and death.

Mumps infection may cause hearing loss, scrotal swelling, and meningitis.

Rubella infection during pregnancy can cause serious fetal abnormalities known as Congenital Rubella Syndrome (CRS).

MMR II Vaccination Schedule
Children
2 doses: at 18 months and 5 years of age

Adults:
2 doses with a minimum interval of 28 days

Elderly:
2 doses with a minimum interval of 28 days

Composition of MMR II
Each 0.5 ml dose contains:

Porcine hydrolyzed gelatin, Medium 199 with Hank’s salts, Minimum Essential Medium (Eagle), Monosodium L-glutamate monohydrate, Neomycin sulfate USP, Phenol red, Potassium phosphate dibasic, Potassium phosphate monobasic, Sorbitol, Sucrose

Side Effect of MMR II Vaccine
Fever

Mild red skin rash appearing 5–12 days after vaccination

Pain, redness, and swelling at the injection site

Contraindication of MMR II
Hypersensitivity to any vaccine component, including neomycin and gelatin, History of severe allergic reaction to previous MR or MMR vaccines, Receipt of immunoglobulin within the last 3 months, History of immunodeficiency, Untreated active tuberculosis, History of immunosuppressive therapy, History of leukemia, lymphoma, or malignancies of the bone marrow or lymphatic system